Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 113 (RNA5SP113) is a pseudogene related to the highly conserved 5S ribosomal RNA gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations preventing proper transcription or translation. Pseudogenes like RNA5SP113 are common for ribosomal RNA multigene families, reflecting the historical duplication and evolutionary birth-and-death processes within genomes. Unlike canonical 5S rRNA genes, which are critical for ribosome structure and protein synthesis, pseudogenes do not encode functional RNA products. Most are not transcribed or translated, though some may have minor roles in gene regulation as non-coding RNAs or antisense transcripts in certain contexts. RNA5SP113 has no known functional, structural, or disease relevance as a therapeutic drug target. If you require information about the canonical functional gene (e.g., 5S ribosomal RNA rather than a pseudogene copy), a distinct entry should be created for the main ribosomal RNA gene rather than the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 113 (RNA5SP113).